2.7(top 20%)
impact factor
4.4K(top 5%)
papers
102.3K(top 5%)
citations
95(top 5%)
h-index
3.0(top 20%)
extended IF
6.2K
all documents
109.0K
doc citations
134(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Albumin-bound paclitaxel: a next-generation taxaneExpert Opinion on Pharmacotherapy2006587
2Toxicity of platinum compoundsExpert Opinion on Pharmacotherapy2003480
3Paclitaxel in cancer therapyExpert Opinion on Pharmacotherapy2002312
4Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and controlExpert Opinion on Pharmacotherapy2004293
5Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and managementExpert Opinion on Pharmacotherapy2007281
6Review of sertraline and its clinical applications in psychiatric disordersExpert Opinion on Pharmacotherapy2001269
7Zolpidem for insomniaExpert Opinion on Pharmacotherapy2012264
8Donepezil: an updateExpert Opinion on Pharmacotherapy2007238
9Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based reviewExpert Opinion on Pharmacotherapy2015238
10An update on pharmacotherapy for leishmaniasisExpert Opinion on Pharmacotherapy2015225
11Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III studyExpert Opinion on Pharmacotherapy2010216
12Leishmaniasis: an update of current pharmacotherapyExpert Opinion on Pharmacotherapy2013214
13Iloperidone, asenapine and lurasidone: a primer on their current statusExpert Opinion on Pharmacotherapy2012192
14Photodynamic therapy in oncologyExpert Opinion on Pharmacotherapy2001187
15Levetiracetam: treatment in epilepsyExpert Opinion on Pharmacotherapy2003187
16A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?Expert Opinion on Pharmacotherapy2010187
17Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?Expert Opinion on Pharmacotherapy2007181
18Treatment strategies underpinning the global programme to eliminate lymphatic filariasisExpert Opinion on Pharmacotherapy2005180
19Long-term use of sildenafilExpert Opinion on Pharmacotherapy2003179
20Paroxetine for the treatment of depression: a critical updateExpert Opinion on Pharmacotherapy2012177
21Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancerExpert Opinion on Pharmacotherapy2009167
22Carbapenems: a potent class of antibioticsExpert Opinion on Pharmacotherapy2008164
23New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver diseaseExpert Opinion on Pharmacotherapy2014159
24Diagnosis and treatment of vitamin D deficiencyExpert Opinion on Pharmacotherapy2008157
25Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobialsExpert Opinion on Pharmacotherapy2015157
26Pharmacotherapy for dyslipidaemia – current therapies and future agentsExpert Opinion on Pharmacotherapy2003156
27Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's diseaseExpert Opinion on Pharmacotherapy2009155
28Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trialExpert Opinion on Pharmacotherapy2009148
29The use of cephalosporins for gonorrhea: the impending problem of resistanceExpert Opinion on Pharmacotherapy2009147
30Treatment of central sensitization in patients with ‘unexplained’ chronic pain: an updateExpert Opinion on Pharmacotherapy2014144
31Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment reviewExpert Opinion on Pharmacotherapy2018144
32The economic burden of depression in the US: societal and patient perspectivesExpert Opinion on Pharmacotherapy2005141
33An update on the medical management of listeriosisExpert Opinion on Pharmacotherapy2004137
34Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic painExpert Opinion on Pharmacotherapy2006137
35Antimicrobial peptides: therapeutic potentialExpert Opinion on Pharmacotherapy2006137
36Ziconotide: an update and reviewExpert Opinion on Pharmacotherapy2008136
37Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapyExpert Opinion on Pharmacotherapy2002135
38Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?Expert Opinion on Pharmacotherapy2016135
39Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmiasExpert Opinion on Pharmacotherapy2000134
40Sorafenib: a clinical and pharmacologic reviewExpert Opinion on Pharmacotherapy2010134
41Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patientsExpert Opinion on Pharmacotherapy2013130
42Colon cancer: preventive agents and the present status of chemopreventionExpert Opinion on Pharmacotherapy2009129
43The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis IExpert Opinion on Pharmacotherapy2005128
44Mechanistic and functional differentiation of tapentadol and tramadolExpert Opinion on Pharmacotherapy2012128
45Insulin detemir: from concept to clinical experienceExpert Opinion on Pharmacotherapy2006125
46Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infectionsExpert Opinion on Pharmacotherapy2006125
47Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological diseaseExpert Opinion on Pharmacotherapy2009125
48Current and emerging medications for the treatment of leishmaniasisExpert Opinion on Pharmacotherapy2019125
49Giardiasis: a pharmacotherapy reviewExpert Opinion on Pharmacotherapy2007123
50Ziconotide: a clinical update and pharmacologic reviewExpert Opinion on Pharmacotherapy2013123